Literature DB >> 29033510

Admission Value of Serum Cathepsin D Level Can be Useful for Predicting In-Hospital Mortality in Patients with NSTEMI.

Harun Kundi1, Ahmet Balun1, Hulya Cicekcioglu2, Mustafa Cetin1, Emrullah Kiziltunc1, Canan Topcuoglu2, Muhammed Fevzi Kilinckaya2, Ender Ornek1.   

Abstract

BACKGROUND: We aimed to investigate the association of serum cathepsin D levels with in-hospital mortality and Syntax scores (SXscore) in non-ST elevation myocardial infarction (NSTEMI) patients.
METHODS: A total of 88 patients were included in the study. The patients were divided into two groups: those with in-hospital mortality (-), and those with in-hospital mortality (+). The receiver operating characteristics curve was used to show the sensitivity and specificity of serum cathepsin D levels, and the optimal cut-off value for predicting in-hospital mortality and high SXscore.
RESULTS: Patients with (+) in-hospital mortality and high SXscore had lower serum cathepsin D levels compared to the patients with (-) in-hospital mortality and low SXscore. Using a cutoff score of < 16 for the cathepsin D level, in-hospital mortality was predicted with a sensitivity and specificity of 73.4% and 77.6%, respectively, and also predicted high SXscore with a sensitivity and specificity of 72.4% and 67.6%, respectively.
CONCLUSIONS: Serum cathepsin D levels established upon admission were significantly and independently lower in NSTEMI patients with high rate of mortality, high SXscores, and low left ventricular ejection fraction.

Entities:  

Keywords:  Non-ST elevation myocardial infarction; Serum cathepsin D; Syntax score

Year:  2017        PMID: 29033510      PMCID: PMC5534419          DOI: 10.6515/acs20170129a

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  21 in total

1.  Usefulness of the SYNTAX score to predict "no reflow" in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Authors:  Michael Magro; Sjoerd T Nauta; Cihan Simsek; Eric Boersma; Elco van der Heide; Evelyn Regar; Ron T van Domburg; Felix Zijlstra; Patrick W Serruys; Robert Jan van Geuns
Journal:  Am J Cardiol       Date:  2011-12-15       Impact factor: 2.778

Review 2.  Coronary stents: current status.

Authors:  Scot Garg; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2010-08-31       Impact factor: 24.094

3.  Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease.

Authors:  Davide Capodanno; Maria Elena Di Salvo; Glauco Cincotta; Marco Miano; Claudia Tamburino; Corrado Tamburino
Journal:  Circ Cardiovasc Interv       Date:  2009-06-30       Impact factor: 6.546

4.  Association of thiol/disulfide ratio with syntax score in patients with NSTEMI.

Authors:  Harun Kundi; Özcan Erel; Ahmet Balun; Hülya Çiçekçioğlu; Mustafa Cetin; Emrullah Kiziltunç; Salim Neşelioğlu; Canan Topçuoğlu; Ender Örnek
Journal:  Scand Cardiovasc J       Date:  2015-03-02       Impact factor: 1.589

5.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Kristian Thygesen; Joseph S Alpert; Harvey D White; Allan S Jaffe; Hugo A Katus; Fred S Apple; Bertil Lindahl; David A Morrow; Bernard R Chaitman; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Jeroen J Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasche; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; Jose-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis; Jeroen J Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A Popescu; Zeljko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; Joao Morais; Carlos Aguiar; Wael Almahmeed; David O Arnar; Fabio Barili; Kenneth D Bloch; Ann F Bolger; Hans Erik Botker; Biykem Bozkurt; Raffaele Bugiardini; Christopher Cannon; James de Lemos; Franz R Eberli; Edgardo Escobar; Mark Hlatky; Stefan James; Karl B Kern; David J Moliterno; Christian Mueller; Aleksandar N Neskovic; Burkert Mathias Pieske; Steven P Schulman; Robert F Storey; Kathryn A Taubert; Pascal Vranckx; Daniel R Wagner
Journal:  J Am Coll Cardiol       Date:  2012-09-05       Impact factor: 24.094

6.  Association of monocyte/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease.

Authors:  H Kundi; E Kiziltunc; M Cetin; H Cicekcioglu; Z G Cetin; G Cicek; E Ornek
Journal:  Herz       Date:  2016-01-11       Impact factor: 1.443

7.  SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: an ACUITY trial substudy.

Authors:  Mayank Yadav; Philippe Généreux; Tullio Palmerini; Adriano Caixeta; Mahesh V Madhavan; Ke Xu; Sorin J Brener; Roxana Mehran; Gregg W Stone
Journal:  Catheter Cardiovasc Interv       Date:  2014-06-17       Impact factor: 2.692

8.  Role of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI.

Authors:  Aylin Hatice Yamac; Emrah Sevgili; Sitki Kucukbuzcu; Muharrem Nasifov; Ziya Ismailoglu; Elif Kilic; Cilem Ercan; Parviz Jafarov; Hüseyin Uyarel; Ahmet Bacaksiz
Journal:  Herz       Date:  2015-04-25       Impact factor: 1.443

9.  A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

Authors:  Denise Hilfiker-Kleiner; Karol Kaminski; Edith Podewski; Tomasz Bonda; Arnd Schaefer; Karen Sliwa; Olaf Forster; Anja Quint; Ulf Landmesser; Carola Doerries; Maren Luchtefeld; Valeria Poli; Michael D Schneider; Jean-Luc Balligand; Fanny Desjardins; Aftab Ansari; Ingrid Struman; Ngoc Q N Nguyen; Nils H Zschemisch; Gunnar Klein; Gerd Heusch; Rainer Schulz; Andres Hilfiker; Helmut Drexler
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

Review 10.  Cathepsin D--many functions of one aspartic protease.

Authors:  Petr Benes; Vaclav Vetvicka; Martin Fusek
Journal:  Crit Rev Oncol Hematol       Date:  2008-04-08       Impact factor: 6.312

View more
  4 in total

1.  Brain Perfusion Matters: From Pituitary Function to Blood Pressure Control during Acute Ischemic Stroke.

Authors:  Tzung-Dau Wang
Journal:  Acta Cardiol Sin       Date:  2018-11       Impact factor: 2.672

2.  Platelet proteome changes in dogs with congestive heart failure.

Authors:  Pinar Levent; Meriç Kocaturk; Emel Akgun; Ahmet Saril; Ozge Cevik; Ahmet Tarik Baykal; Ryou Tanaka; Jose Joaquin Ceron; Zeki Yilmaz
Journal:  BMC Vet Res       Date:  2020-11-30       Impact factor: 2.741

3.  Proteomic exploration of common pathophysiological pathways in diabetes and cardiovascular disease.

Authors:  John Molvin; Amra Jujić; Olle Melander; Manan Pareek; Lennart Råstam; Ulf Lindblad; Bledar Daka; Margrét Leósdóttir; Peter M Nilsson; Michael H Olsen; Martin Magnusson
Journal:  ESC Heart Fail       Date:  2020-10-13

4.  Myocardial cathepsin D is downregulated in sudden cardiac death.

Authors:  Yu Kakimoto; Ayumi Sasaki; Maki Niioka; Noboru Kawabe; Motoki Osawa
Journal:  PLoS One       Date:  2020-03-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.